Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.
Coltamai
L
L
Department of Medicine, Division of Nephrology and Hypertension, Central University Hospital of Vaud, Lausanne, Switzerland.
Bucher
M
M
Maillard
M P
MP
Shukla
U
U
Bohidar
N
N
Haskell
L
L
Bertelsen
K
K
Fedgchin
M
M
Vogt
B
B
Burnier
M
M
D000293:Adolescent; D000328:Adult; D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines / Q000494:pharmacology*; D018592:Cross-Over Studies; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D017483:Receptors, Vasopressin / Q000502:physiology; D012039:Regional Blood Flow / Q000187:drug effects* / Q000502:physiology; D012867:Skin / Q000098:blood supply* / Q000187:drug effects*; D013141:Spiro Compounds / Q000494:pharmacology*; D055815:Young Adult
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; C526925:RWJ-676070; D017483:Receptors, Vasopressin; D013141:Spiro Compounds